TRIO PHARMA ApS: Financial statements 2018
CVR: 36499281
Source: annual report 2018, Danish Business Authority
01/05/2017 – 30/04/2018
TRIO PHARMA ApS (CVR 36499281) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 28,357 and a net result of DKK -271,678 compared with DKK -244,148 the year before. Equity in the 2018 report amounted to DKK -517,709.
- Gross Profit
- DKK 28,357
- Profit/Loss
- DKK -271,678
- Equity
- DKK -517,709
- Total Assets
- DKK 431,368
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 28 t. | -272 t. | -518 t. | - |
| 2017 | - | -123 t. | -244 t. | -246 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout TRIO PHARMA ApS
TRIO PHARMA ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2015. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christian Bo Ratje. The board consists of Michael John Ratje (chair), Christian Bo Ratje and Kirstine Laura Ratje-Johansen. The company is owned by STINE RATJE HOLDING ApS and CHRISTIAN RATJE HOLDING ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK -411,555 and a net result of DKK -1,170,880 compared with DKK -489,664 the year before. Equity in the 2025 report amounted to DKK -2,593,533.